Jan Palfijn Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
1995
NCT00617513
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Fertility Center AZ Jan Palfijn Gent | Jan Palfijn Ziekenhuis, Merksem

Active Ingredients

Drugs in Phase 4 Trials (1)

goserelin (zoladex) (1 trial)

Drugs in Phase 2 Trials (2)

apremilast (otezla) (1 trial)

prucalopride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Psoriatic (Phase 2)

Constipation (Phase 2)

Endometriosis (Phase 4)

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3